Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6505-37-9

Post Buying Request

6505-37-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6505-37-9 Usage

Structure

A derivative of benzaldehyde with chlorine atoms at positions 2 and 6, and a methoxy group at position 3.

Usage

Intermediate in the synthesis of pharmaceuticals and agrochemicals; manufacture of dyes; organic synthesis.

Industrial applications

Various, including research due to its unique chemical properties.

Check Digit Verification of cas no

The CAS Registry Mumber 6505-37-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,0 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6505-37:
(6*6)+(5*5)+(4*0)+(3*5)+(2*3)+(1*7)=89
89 % 10 = 9
So 6505-37-9 is a valid CAS Registry Number.

6505-37-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dichloro-3-methoxybenzaldehyde

1.2 Other means of identification

Product number -
Other names 2,6-dichloro-3-methoxy-benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6505-37-9 SDS

6505-37-9Relevant articles and documents

CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

-

Page/Page column 68-69, (2008/06/13)

The present invention discloses compounds of Formula I: (I) having 11beta -HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6505-37-9